Fund Raising Update: Round completed

21-09-2020

In only ten days Leadartis has completed 100% of its fund-raising needs.

We thank you all for your support! We will allow a small overfunding amount, act quickly if you don´t want to miss out!! Visit the following link should you are still interested in participating. https://capitalcell.es/campaign/leadartis/

Regards, Juan J. Perez Villar, Leadartis CEO

Latest News

Leadartis announces the publication "An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad anti-tumor activity in humanized murine cancer models without toxicity” in Clinical Cancer Research
02-04-2021
Leadartis reaches a major milestone with the demonstration of absence of toxicity of its drug candidate in preclinical models
13-01-2021

Leadartis reaches a major milestone with the demonstration of...

Leadartis featured in EXPANSION as a ‘Start up’ that leads the fight against cancer
10-11-2020

...